Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Patrick Lamy currently holds 29,891 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick Lamy has been a net seller of AKRO stock. They have purchased $0 and sold $118.6K worth of shares.
Patrick Lamy's most recent insider trade was on Dec 9, 2025, when they sold 26,832 shares at $0.00 per share.
Patrick Lamy serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 8 insider transactions totaling $118.6K over their tenure at the company.
Patrick Lamy holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Patrick Lamy has shown a selling trading pattern, with $0 in total purchases and $118.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Patrick Lamy was on Jul 1, 2025, when they sold $105.8K worth of AKRO shares. This transaction involved 2,000 shares at $52.88 per share.
Patrick Lamy currently owns 29,891 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Patrick Lamy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Patrick Lamy has 8 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Patrick Lamy and 40,000+ other insiders.